Loading...
Biohacking breakthroughs and longevity science weekly.
University of Washington’s AI protein design lifts synthetic protein accuracy 27% per Lab Manager. BTC trades at $74,671 amid extreme fear, while longevity VC funding climbs 15% YoY.
Zhang et al.'s AI protein engineering advances synthetic protein design 80% in benchmarks (bioRxiv 2026). Biohacking and longevity gain traction as crypto fear index hits 21.
AI protein design reaches 90% accuracy using DeepMind's 200M AlphaFold structures, accelerating synthetic proteins for longevity therapies. Markets cautious as BTC hits $75,016.
Lab Manager's AI protein engineering method achieves 40% higher success rates in designing synthetic proteins for longevity therapeutics. Surging VC funding and BTC at $74,987 highlight biohacking finance momentum.
Colorado teachers report better conditions, but AI anxiety drives burnout. Zone 2 training (150 min/week) and cold exposure extend healthspan amid edtech shifts.
OpenAI expands cybersecurity model access, protecting biohacker wearables and longevity data amid Anthropic Mythos rivalry. BTC climbs to $74,862 with Fear & Greed Index at 23.
Florida investigators recovered $450K in a crypto scam targeting a biohacker, highlighting risks for longevity funding amid BTC volatility and extreme market fear.
AI low-dose CT lung cancer screening enhances the NLST trial's 20% mortality reduction. Cureus review details clinical challenges as biohackers integrate into longevity protocols.
AI cybersecurity defends longevity wearables from breaches amid rising AI threats. Crypto Fear & Greed Index at 21 signals caution as Bitcoin surges to $75,099 USD and Ethereum holds at $2,336 USD.
AI medical tools cut breast cancer false positives 71% as second readers per JAMA 2020 study. FDA-cleared diagnostics enhance longevity tracking and draw $4.5B VC funding.
Meta AI investments power longevity breakthroughs with Llama models amid Bitcoin's 1% climb to $74,981. Fear & Greed Index at 23 signals tech payoff potential for biohacking investors.
Cureus paper validates AI lung cancer screening at 94% sensitivity on 8,500 low-dose CT scans. Crypto Fear & Greed Index drops to 23, driving $2.1B VC into longevity health tech.
Lab Manager details data-driven AI protein design improving synthetic protein functions. Longevity biotech advances amid BTC at $75,717 and rising DeSci funding.
AI cybersecurity defends longevity wearables from breaches amid rising AI threats. Crypto Fear & Greed Index at 21 signals caution as Bitcoin surges to $75,099 USD and Ethereum holds at $2,336 USD.
AI can't replace human scientists in longevity research despite AlphaFold's 200 million protein structures accelerating drug design. Fear & Greed Index at 21 undervalues biotech amid $4.2B VC funding.
Colorado teachers report better conditions, but AI anxiety drives burnout. Zone 2 training (150 min/week) and cold exposure extend healthspan amid edtech shifts.
AI business training equips biohackers amid Crypto Fear & Greed Index at 21. Bitcoin dips to $74,663 on April 17, 2026, signaling funding chances for longevity ventures.
University of Washington’s AI protein design lifts synthetic protein accuracy 27% per Lab Manager. BTC trades at $74,671 amid extreme fear, while longevity VC funding climbs 15% YoY.
